89 related articles for article (PubMed ID: 28714291)
1. Mechanism of midline defect-causing mutation P151L in MID1 revealed.
Nicholson LK
FEBS J; 2017 Jul; 284(14):2167-2169. PubMed ID: 28714291
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional observations of the P151L MID1 mutation reveal alpha4 plays a significant role in X-linked Opitz Syndrome.
Wright KM; Du H; Massiah MA
FEBS J; 2017 Jul; 284(14):2183-2193. PubMed ID: 28548391
[TBL] [Abstract][Full Text] [Related]
3. MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.
Du H; Wu K; Didoronkute A; Levy MV; Todi N; Shchelokova A; Massiah MA
PLoS One; 2014; 9(9):e107428. PubMed ID: 25207814
[TBL] [Abstract][Full Text] [Related]
4. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
[TBL] [Abstract][Full Text] [Related]
5. XLOS-observed mutations of MID1 Bbox1 domain cause domain unfolding.
Wright KM; Wu K; Babatunde O; Du H; Massiah MA
PLoS One; 2014; 9(9):e107537. PubMed ID: 25216264
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase MID1/TRIM18 promotes atypical ubiquitination of the BRCA2-associated factor 35, BRAF35.
Zanchetta ME; Napolitano LMR; Maddalo D; Meroni G
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1844-1854. PubMed ID: 28760657
[TBL] [Abstract][Full Text] [Related]
7. The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.
Du H; Huang Y; Zaghlula M; Walters E; Cox TC; Massiah MA
J Biol Chem; 2013 Jul; 288(29):21341-21350. PubMed ID: 23740247
[TBL] [Abstract][Full Text] [Related]
8. B-box1 Domain of MID1 Interacts with the Ube2D1 E2 Enzyme Differently Than RING E3 Ligases.
Kaur A; Gladu EM; Wright KM; Webb JA; Massiah MA
Biochemistry; 2023 Mar; 62(5):1012-1025. PubMed ID: 36820504
[TBL] [Abstract][Full Text] [Related]
9. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.
Trockenbacher A; Suckow V; Foerster J; Winter J; Krauss S; Ropers HH; Schneider R; Schweiger S
Nat Genet; 2001 Nov; 29(3):287-94. PubMed ID: 11685209
[TBL] [Abstract][Full Text] [Related]
10. Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination.
McConnell JL; Watkins GR; Soss SE; Franz HS; McCorvey LR; Spiller BW; Chazin WJ; Wadzinski BE
Biochemistry; 2010 Mar; 49(8):1713-8. PubMed ID: 20092282
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.
Liu J; Prickett TD; Elliott E; Meroni G; Brautigan DL
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6650-5. PubMed ID: 11371618
[TBL] [Abstract][Full Text] [Related]
12. NMR studies of the C-terminus of alpha4 reveal possible mechanism of its interaction with MID1 and protein phosphatase 2A.
Du H; Massiah MA
PLoS One; 2011; 6(12):e28877. PubMed ID: 22194938
[TBL] [Abstract][Full Text] [Related]
13. A structure-function study of MID1 mutations associated with a mild Opitz phenotype.
Mnayer L; Khuri S; Merheby HA; Meroni G; Elsas LJ
Mol Genet Metab; 2006 Mar; 87(3):198-203. PubMed ID: 16378742
[TBL] [Abstract][Full Text] [Related]
14. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
Berti C; Fontanella B; Ferrentino R; Meroni G
BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
[TBL] [Abstract][Full Text] [Related]
15. Exon 2 duplication of the MID1 gene in a patient with a mild phenotype of Opitz G/BBB syndrome.
Hüning I; Kutsche K; Rajaei S; Erlandsson A; Lovmar L; Rundberg J; Stefanova M
Eur J Med Genet; 2013 Apr; 56(4):188-91. PubMed ID: 23354372
[TBL] [Abstract][Full Text] [Related]
16. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
[TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.
LeNoue-Newton M; Watkins GR; Zou P; Germane KL; McCorvey LR; Wadzinski BE; Spiller BW
J Biol Chem; 2011 May; 286(20):17665-71. PubMed ID: 21454489
[TBL] [Abstract][Full Text] [Related]
18. The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex.
Aranda-Orgillés B; Trockenbacher A; Winter J; Aigner J; Köhler A; Jastrzebska E; Stahl J; Müller EC; Otto A; Wanker EE; Schneider R; Schweiger S
Hum Genet; 2008 Mar; 123(2):163-76. PubMed ID: 18172692
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the microtubule-targeting COS domain of MID1.
Wright KM; Du H; Dagnachew M; Massiah MA
FEBS J; 2016 Aug; 283(16):3089-102. PubMed ID: 27367845
[TBL] [Abstract][Full Text] [Related]
20. Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit α4, altering PP2A stability and microtubule-associated protein phosphorylation.
Watkins GR; Wang N; Mazalouskas MD; Gomez RJ; Guthrie CR; Kraemer BC; Schweiger S; Spiller BW; Wadzinski BE
J Biol Chem; 2012 Jul; 287(29):24207-15. PubMed ID: 22613722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
